Review ArticleUpdate on the management of multiple sclerosis during the COVID-19 pandemic and post pandemic: An international consensus statement
Keywords
COVID-19
Multiple sclerosis
Disease-modifying treatment
Telemedicine
Pharmacovigilance
Abbreviations
ADWP
Autoimmune Diseases Working Party
ARDS
acute respiratory distress syndrome
COVID-19
coronavirus disease 2019
DMF
dimethyl fumarate
DMT
disease-modifying therapy
HSCT
hematopoietic stem cell transplantation
ICU
intensive care unit
IRT
immune reconstitution therapies
MRI
magnetic resonance imaging
MS
multiple sclerosis
MSIS-29
Multiple Sclerosis Impact Scale
MuSC-19
Multiple Sclerosis and COVID-19
PDDS
Patient Determined Disease Steps
PML
progressive multifocal leukoencephalopathy
pwMS
people with multiple sclerosis
RECOVERY
Randomized Evaluation of COVID-19 Therapy
SARS-CoV-2
severe acute respiratory syndrome coronavirus 2
S1PR
sphingosine 1-phosphate receptor
triMS.online
Treatment and Research in Multiple Sclerosis online
URT
upper respiratory tract
WHO
World Health Organization
Cited by (0)
© 2021 Elsevier B.V. All rights reserved.